Giannoula Lakka Klement

Giannoula Lakka Klement has a diverse and extensive work experience in the field of medicine and research. Giannoula began their career as an Instructor at Harvard University, focusing on developing novel anti-angiogenic therapies for benign and malignant vascular tumors. Giannoula also served as a Pediatric Oncology Attending at Dana-Farber Cancer Institute, specializing in disease-specific treatment for benign vascular tumors and vascular anomalies.

In 2009, Lakka Klement joined Tufts University as an Assistant Professor, further exploring their interest in experimental therapeutics and the role of platelets in tumor angiogenesis. Giannoula also worked as an Investigator at Caritas St. Elizabeth's Medical Center/Tufts School of Medicine during this time.

From 2012 to 2015, Lakka Klement served as the Director of the Newman Lakka Institute for Personalized Cancer Care at The Floating Hospital. In this role, they focused on enhancing knowledge about molecular therapies and promoting a close relationship between clinical care and research.

Later, Lakka Klement held various positions at Floating Hospital for Children at Tufts Medical Center, including Pediatric Hematology/Oncology Attending and Chief of Academic and Research Affairs. Giannoula specialized in providing specialized treatment and management recommendations for children with rare cancers or cancer predisposing syndromes. Giannoula also played a role in the development of novel therapeutic approaches for previously untreated patient populations with various vascular disorders.

Continuing their career progression, Lakka Klement became an Associate Professor at Tufts University School of Medicine in 2015, further solidifying their expertise in the field.

Most recently, they have taken up the position of Chief Science Officer at Hessian Labs since December 2019, where they continue to contribute their knowledge and experience in scientific research and innovation. Prior to this, Lakka Klement also held the role of Chief Medical Officer at CSTS Health Care in 2018.

Overall, Giannoula Lakka Klement's work experience demonstrates their strong commitment to advancing medical research, improving patient care, and specialization in pediatric hematology/oncology and vascular anomalies.

Giannoula Lakka Klement began their education by earning a Bachelor's Degree in Biology/Biological Sciences from the University of Toronto from 1979 to 1982. Concurrently, they also pursued a Bachelor of Science degree at the same institution. Giannoula then attended McMaster University from 1989 to 1992, where they obtained their Doctor of Medicine (M.D.) degree. Continuing their academic pursuits, Klement attended Harvard University as a Neuro Oncology Fellow from 2001 to 2003.